Seminars in Pediatric Surgery
Volume 15, Issue 3 , Pages 142-152 , August 2006

Immunosuppression in pediatric solid organ transplantation

  • Avinash Agarwal, MD

      Affiliations

    • Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana
    • ,
  • Mark D. Pescovitz, MD

      Affiliations

    • Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana
    • Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana.
    • Corresponding Author InformationAddress reprint requests and correspondence: Mark D. Pescovitz, MD, Indiana University School of Medicine, Rm UH4601, 550 N University Blvd., Indianapolis, IN 46202.

References 

  1. Murray J . Nobel Prize Lecture (First successful transplant in man) . In:  Terasaki P editors. History of Transplantation (Thirty Five Recollections) . Los Angeles, CA: UCLA Tissue Typing Laboratory; 1991;
  2. Magee JC , Bucuvalas JC , Farmer DG , Harmon WE , Hulbert-Shearon TE , Mendeloff EN . Pediatric transplantation . Am J Transplant . 2004;9(suppl 4):54–71
  3. Al-Akash S , Ettenger R . Kidney transplantation in children . In:  Danovitch G editors. Handbook of Kidney Transplantation . Philadelphia, PA: Lippincott Williams & Wilkins; 2005;p. 414–449
  4. Benfield MR , McDonald RA , Bartosh S , Ho PL , Harmon W . Changing trends in pediatric transplantation (2001 Annual Report of the North American Pediatric Renal Transplant Cooperative Study) . Pediatr Transplant . 2003;7(4):321–335
  5. North American Pediatric Renal Transplant Cooperative Study Annual Report . 2005;
  6. Hariharan S . Long-term renal transplant management. Introduction . Am J Kidney Dis . 2001;38(6, suppl 6):S1
  7. Tejani A , Ho PL , Emmett L , Stablein DM . Reduction in acute rejections decreases chronic rejection graft failure in children (a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)) . Am J Transplant . 2002;2(2):142–147
  8. Rianthavorn P , Ettenger RB . Medication non-adherence in the adolescent renal transplant recipient (a clinician’s viewpoint) . Pediatr Transplant . 2005;9(3):398–407
  9. Gibson J , Medawar P . The fate of skin homografts in man . J Anat . 1943;77:299–310
  10. Medawar P . Behaviour and fate of skin autografts and skin homografts in rabbits . J Anat . 1944;78:157–176
  11. Marguilies D , McCluskey J . The major histocompatability complex and its encoded proteins . In:  Paul W editors. Fundamental Immunology . Philadelphia, PA: Lippincott-Raven; 2003;p. 571
  12. Campbell RD , Trowsdale J . Map of the human MHC . Immunol Today . 1993;14(7):349–352
  13. Rotzschke O , Falk K , Faath S , Rammensee HG . On the nature of peptides involved in T cell alloreactivity . J Exp Med . 1991;174(5):1059–1071
  14. Benichou G , Fedoseyeva EV . The contribution of peptides to T cell allorecognition and allograft rejection . Int Rev Immunol . 1996;13(3):231–243
  15. Cantrell D . T cell antigen receptor signal transduction pathways . Annu Rev Immunol . 1996;14:259–274
  16. Lafferty KJ , Cunningham AJ . A new analysis of allogeneic interactions . Aust J Exp Biol Med Sci . 1975;53(1):27–42
  17. Schwartz RH , Mueller DL , Jenkins MK , Quill H . T-cell clonal anergy . Cold Spring Harb Symp Quant Biol . 1989;54:605–610
  18. Chambers CA , Allison JP . Co-stimulation in T cell responses . Curr Opin Immunol . 1997;9(3):396–404
  19. Parish CR . The relationship between humoral and cell-mediated immunity . Transplant Rev . 1972;13:35–66
  20. Mosmann TR , Coffman RL . TH1 and TH2 cells (different patterns of lymphokine secretion lead to different functional properties) . Annu Rev Immunol . 1989;7:145–173
  21. Piccotti JR , Chan SY , VanBuskirk AM , Eichwald EJ , Bishop DK . Are Th2 helper T lymphocytes beneficial, deleterious, or irrelevant in promoting allograft survival? . Transplantation . 1997;63(5):619–624
  22. Morris RE . New small molecule immunosuppressants for transplantation (review of essential concepts) . J Heart Lung Transplant . 1993;12(6):S275–S286
  23. Rebellato LM , Gross U , Verbanac KM , Thomas JM . A comprehensive definition of the major antibody specificities in polyclonal rabbit antithymocyte globulin . Transplantation . 1994;57(5):685–694
  24. Chatenoud L . Use of CD3 antibodies in transplantation and autoimmune diseases . Transplant Proc . 1994;26(6):3191–3193
  25. Waldmann TA . The IL-2/IL-2 receptor system (a target for rational immune intervention) . Immunol Today . 1993;14(6):264–270
  26. Kahan BD , Ponticelli C . Immunosuppressive drugs (molecular and cellular mechanisms of action) . In: Principles and Practices of Renal Transplantation . Malden: Martin Dunitz; 2000;p. 315–349
  27. Winkelstein A . The effects of azathioprine and 6 MP on immunity . J Immunopharmacol . 1979;1(4):429–454
  28. Allison AC , Eugui EM . Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF) . Clin Transplant . 1996;10(1):77–84
  29. Cupps TR , Fauci AS . Corticosteroid-mediated immunoregulation in man . Immunol Rev . 1982;65:133–155
  30. Sigal NH , Dumont FJ . Cyclosporin A, FK-506, and rapamycin (pharmacologic probes of lymphocyte signal transduction) . Annu Rev Immunol . 1992;10:519–560
  31. North American Pediatric Renal Transplant Cooperative Study Annual Report . 2004;
  32. Tejani A , Sullivan EK . The impact of acute rejection on chronic rejection (a report of the North American Pediatric Renal Transplant Cooperative Study) . Pediatr Transplant . 2000;4(2):107–111
  33. Fryer JP , Benedetti E , Gillingham K , Najarian JS , Matas AJ . Steroid-related complications in pediatric kidney transplant recipients in the cyclosporine era . Transplant Proc . 1994;26(1):91–92
  34. Broyer M , Guest G , Gagnadoux MF . Growth rate in children receiving alternate-day corticosteroid treatment after kidney transplantation . J Pediatr . 1992;120(5):721–725
  35. Feldhoff C , Goldman AI , Najarian JS , Mauer SM . A comparison of alternate day and daily steroid therapy in children following renal transplantation . Int J Pediatr Nephrol . 1984;5(1):11–14
  36. Chao SM , Jones CL , Powell HR , Johnstone L , Francis DM , Becker GJ , et al.   Triple immunosuppression with subsequent prednisolone withdrawal (6 years’ experience in paediatric renal allograft recipients) . Pediatr Nephrol . 1994;8(1):62–69
  37. Ingulli E , Sharma V , Singh A , Suthanthiran M , Tejani A . Steroid withdrawal, rejection and the mixed lymphocyte reaction in children after renal transplantation . Kidney Int Suppl . 1993;43:S36–S39
  38. Reisman L , Lieberman KV , Burrows L , Schanzer H . Follow-up of cyclosporine-treated pediatric renal allograft recipients after cessation of prednisone . Transplantation . 1990;49(1):76–80
  39. Roberti I , Reisman L , Lieberman KV , Burrows L . Risk of steroid withdrawal in pediatric renal allograft recipients (a 5-year follow-up) . Clin Transplant . 1994;8(4):405–408
  40. Hricik DE , Schulak JA . Metabolic effects of steroid withdrawal in adult renal transplant recipients . Kidney Int Suppl . 1993;43:S26–S29
  41. Oberholzer J , John E , Lumpaopong A , Testa G , Sankary HN , Briars L , et al.   Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients . Pediatr Transplant . 2005;9(4):456–463
  42. Sarwal MM , Vidhun JR , Alexander SR , Satterwhite T , Millan M , Salvatierra O . Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation . Transplantation . 2003;76(9):1331–1339
  43. Sarwal MM , Yorgin PD , Alexander S , Millan MT , Belson A , Belanger N , et al.   Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation . Transplantation . 2001;72(1):13–21
  44. McDonald R , Donaldson L , Emmett L , Tejani A . A decade of living donor transplantation in North American children (the 1998 annual report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)) . Pediatr Transplant . 2000;4(3):221–234
  45. Elshihabi I , Chavers B , Donaldson L , Emmett L , Tejani A . Continuing improvement in cadaver donor graft survival in North American children (the 1998 annual report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)) . Pediatr Transplant . 2000;4(3):235–246
  46. Benfield MR , Tejani A , Harmon WE , McDonald R , Stablein DM , McIntosh M , et al.   A randomized multicenter trial of OKT3 mAbs induction compared with intravenous cyclosporine in pediatric renal transplantation . Pediatr Transplant . 2005;9(3):282–292
  47. Chin C , Pittson S , Luikart H , Bernstein D , Robbins R , Reitz B , et al.   Induction therapy for pediatric and adult heart transplantation (comparison between OKT3 and daclizumab) . Transplantation . 2005;80(4):477–481
  48. Ganschow R , Broering DC , Stuerenburg I , Rogiers X , Hellwege HH , Burdelski M . First experience with basiliximab in pediatric liver graft recipients . Pediatr Transplant . 2001;5(5):353–358
  49. Heffron TG , Pillen T , Smallwood GA , Welch D , Oakley B , Romero R . Pediatric liver transplantation with daclizumab induction . Transplantation . 2003;75(12):2040–2043
  50. Asensio M , Margarit C , Chavez R , Ortega J , Charco R , Iglesias J . Induction with basiliximab reduces acute rejection in pediatric liver transplant patients treated with tacrolimus and steroids . Transplant Proc . 2002;34(5):1970–1971
  51. Smith JM , Stablein D , Singh A , Harmon W , McDonald RA . Decreased risk of renal allograft thrombosis associated with interleukin-2 receptor antagonists (a report of the NAPRTCS) . Am J Transplant . 2006;6(3):585–588
  52. Knechtle SJ . Present experience with Campath-1H in organ transplantation and its potential use in pediatric recipients . Pediatr Transplant . 2004;8(2):106–112
  53. Tzakis AG , Kato T , Nishida S , Levi DM , Madariaga JR , Nery JR , et al.   Preliminary experience with campath 1H (C1H) in intestinal and liver transplantation . Transplantation . 2003;75(8):1227–1231
  54. Bartosh SM , Knechtle SJ , Sollinger HW . Campath-1H use in pediatric renal transplantation . Am J Transplant . 2005;5(6):1569–1573
  55. Ault BH , Honaker MR , Osama Gaber A , Jones DP , Duhart BT , Powell SL , et al.   Short-term outcomes of Thymoglobulin induction in pediatric renal transplant recipients . Pediatr Nephrol . 2002;17(10):815–818
  56. Kamel MH , Mohan P , Little DM , Awan A , Hickey DP . Rabbit antithymocyte globulin as induction immunotherapy for pediatric deceased donor kidney transplantation . J Urol . 2005;174(2):703–707
  57. Di Filippo S , Boissonnat P , Sassolas F , Robin J , Ninet J , Champsaur G , et al.   Rabbit antithymocyte globulin as induction immunotherapy in pediatric heart transplantation . Transplantation . 2003;75(3):354–358
  58. Boucek RJ , Naftel D , Boucek MM , Chinnock R , Morrow RW , Pahl E , et al.   Induction immunotherapy in pediatric heart transplant recipients (a multicenter study) . J Heart Lung Transplant . 1999;18(5):460–469
  59. Sollinger HW . Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. US Renal Transplant Mycophenolate Mofetil Study Group . Transplantation . 1995;60(3):225–232
  60. Mofetil Cooperative Study Group . Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate . Lancet . 1995;345(8961):1321–1325
  61. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group . A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation . Transplantation . 1996;61(7):1029–1037
  62. Jungraithmayr T , Staskewitz A , Kirste G , Boswald M , Bulla M , Burghard R , et al.   Pediatric renal transplantation with mycophenolate mofetil-based immunosuppression without induction (results after three years) . Transplantation . 2003;75(4):454–461
  63. Ferraris JR , Ghezzi LF , Vallejo G , Piantanida JJ , Araujo JL , Sojo ET . Improved long-term allograft function in pediatric renal transplantation with mycophenolate mofetil . Pediatr Transplant . 2005;9(2):178–182
  64. Hocker B , Weber LT , Bunchman T , Rashford M , Tonshoff B . Mycophenolate mofetil suspension in pediatric renal transplantation (three-year data from the tricontinental trial) . Pediatr Transplant . 2005;9(4):504–511
  65. Levy G , Thervet E , Lake J , Uchida K . Patient management by Neoral C(2) monitoring (an international consensus statement) . Transplantation . 2002;73(9, suppl):S12–S18
  66. Thervet E , Pfeffer P , Scolari MP , Toselli L , Pallardo LM , Chadban S , et al.   Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion . Transplantation . 2003;76(6):903–908
  67. David-Neto E , Araujo LP , Feres Alves C , Sumita N , Romano P , Yagyu EM , et al.   A strategy to calculate cyclosporin A area under the time-concentration curve in pediatric renal transplantation . Pediatr Transplant . 2002;6(4):313–318
  68. Kelles A , Herman J , Tjandra-Maga TB , Van Damme-Lombaerts R . Sandimmune to Neoral conversion and value of abbreviated AUC monitoring in stable pediatric kidney transplant recipients . Pediatr Transplant . 1999;3(4):282–287
  69. Filler G , Feber J , Lepage N , Weiler G , Mai I . Universal approach to pharmacokinetic monitoring of immunosuppressive agents in children . Pediatr Transplant . 2002;6(5):411–418
  70. Meier-Kriesche HU , Kaplan B , Brannan P , Kahan BD , Portman RJ . A limited sampling strategy for the estimation of eight-hour neoral areas under the curve in renal transplantation . Ther Drug Monit . 1998;20(4):401–407
  71. Wigger M , Druckler E , Muscheites J , Stolpe HJ , Kundt G , Wacke R . Cyclosporine peak concentration in relation to the four-hour absorption phase in pediatric renal graft recipients . Transplant Proc . 2001;33(7-8):3126–3127
  72. Ferraresso M , Ghio L , Edefonti A , Vigano S , Boschiero L , Berardinelli L . C0 or C2 driven cyclosporine monitoring in long-term pediatric kidney transplant recipients (is there any threat for chronic rejection development?) . Pediatr Transplant . 2005;9(3):328–331
  73. Sehgal SN . Sirolimus (its discovery, biological properties, and mechanism of action) . Transplant Proc . 2003;35(3, suppl):7S–14S
  74. Abraham RT , Wiederrecht GJ . Immunopharmacology of rapamycin . Annu Rev Immunol . 1996;14:483–510
  75. Schachter AD , Meyers KE , Spaneas LD , Palmer JA , Salmanullah M , Baluarte J , et al.   Short sirolimus half-life in pediatric renal transplant recipients on a calcineurin inhibitor-free protocol . Pediatr Transplant . 2004;8(2):171–177
  76. Vilalta R , Vila A , Nieto J , Callis L . Rapamycin use and rapid withdrawal of calcineurin inhibitors in pediatric renal transplantation . Transplant Proc . 2003;35(2):703–704
  77. El-Sabrout R , Weiss R , Butt F , Delaney V , Qadir M , Hanson P , et al.   Rejection-free protocol using sirolimus-tacrolimus combination for pediatric renal transplant recipients . Transplant Proc . 2002;34(5):1942–1943
  78. El-Sabrout R , Weiss R , Butt F , Rashid I , Delaney V , Qadir M , et al.   Improved lipid profile and blood sugar control in pediatric renal transplant recipients using sirolimus-tacrolimus combination . Transplant Proc . 2002;34(5):1946–1947
  79. Filler G , Womiloju T , Feber J , Lepage N , Christians U . Adding sirolimus to tacrolimus-based immunosuppression in pediatric renal transplant recipients reduces tacrolimus exposure . Am J Transplant . 2005;5(8):2005–2010
  80. Schubert M , Venkataramanan R , Holt DW , Shaw LM , McGhee W , Reyes J , et al.   Pharmacokinetics of sirolimus and tacrolimus in pediatric transplant patients . Am J Transplant . 2004;4(5):767–773
  81. Benfield M , Munoz R , Warshaw B , Bartosh S , Stablein D , McIntosh M . A randomized controlled double-blinded trial of steroid withdrawal in pediatric renal transplantation (a study of the Cooperative Clinical Trials in Pediatric Transplantation (CCTPT)) . American Transplant Congress 2005 . 2005; Seattle, WA
  82. Casas-Melley AT , Falkenstein KP , Flynn LM , Ziegler VL , Dunn SP . Improvement in renal function and rejection control in pediatric liver transplant recipients with the introduction of sirolimus . Pediatr Transplant . 2004;8(4):362–366
  83. Sindhi R , Ganjoo J , McGhee W , Mazariegos G , Reyes J . Preliminary immunosuppression withdrawal strategies with sirolimus in children with liver transplants . Transplant Proc . 2002;34(5):1972–1973
  84. Fishbein TM , Florman S , Gondolesi G , Schiano T , LeLeiko N , Tschernia A , et al.   Intestinal transplantation before and after the introduction of sirolimus . Transplantation . 2002;73(10):1538–1542
  85. Kanj SS , Sharara AI , Clavien PA , Hamilton JD . Cytomegalovirus infection following liver transplantation (review of the literature) . Clin Infect Dis . 1996;22(3):537–549
  86. Patel R , Snydman DR , Rubin RH , Ho M , Pescovitz M , Martin M , et al.   Cytomegalovirus prophylaxis in solid organ transplant recipients . Transplantation . 1996;61(9):1279–1289
  87. Funch DP , Walker AM , Schneider G , Ziyadeh NJ , Pescovitz MD . Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients . Am J Transplant . 2005;5(12):2894–2900
  88. Clark BS , Chang IF , Karpen SJ , Herrera L , Scott JD , Bristow LJ , et al.   Valganciclovir for the prophylaxis of cytomegalovirus disease in pediatric liver transplant recipients . Transplantation . 2004;77(9):1480
  89. Danziger-Isakov LA , Faro A , Sweet S , Michaels MG , Aurora P , Mogayzel PJ , et al.   Variability in standard care for cytomegalovirus prevention and detection in pediatric lung transplantation (survey of eight pediatric lung transplant programs) . Pediatr Transplant . 2003;7(6):469–473
  90. Pescovitz M . Valganciclovir. what is the status in solid organ transplantation . Future Virol . 2006; in press.
  91. Hooper E , Hawkins DM , Kowalski RJ , Post DR , Britz JA , Brooks KC , et al.   Establishing pediatric immune response zones using the Cylex ImmuKnow assay . Clin Transplant . 2005;19(6):834–839

PII: S1055-8586(06)00025-4

doi: 10.1053/j.sempedsurg.2006.03.002

Seminars in Pediatric Surgery
Volume 15, Issue 3 , Pages 142-152 , August 2006

Article Tools